IFRX

InflaRx N.V. IFRX

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,626 of 2,925

Why it scores 25Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$29.3K

Quarter to Dec 31

Net income

$-45.63M

Quarter to Dec 31

Free cash flow

$-35.43M

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$211.56M total
SUVRETTA CAPITAL MANAGEMENT, LLC
$51.37M+189.1%
TCG Crossover Management, LLC
$32.48MNew
FMR LLC
$18.29MNew
Commodore Capital LP
$16.35MNew
Spruce Street Capital LP
$11.99MNew
683 Capital Management, LLC
$11.35M+52.8%
FARALLON CAPITAL MANAGEMENT LLC
$7.45MNew
StemPoint Capital LP
$7.23MNew
GREAT POINT PARTNERS LLC
$6.82MNew
ADAR1 Capital Management, LLC
$6.72M+1795.5%
Kalehua Capital Management LLC
$6.49MNew
AMERIPRISE FINANCIAL INC
$5.76MNew
Woodline Partners LP
$4.72MNew
Squadron Capital Management LLC
$4.48MNew
Eversept Partners, LP
$2.92M-25.8%
FRANKLIN RESOURCES INC
$2.32MNew
MORGAN STANLEY
$2.05M-22.1%
LEUCADIA NATIONAL CORP
$1.74MNew
MARSHALL WACE, LLP
$1.59M+28.3%
MILLENNIUM MANAGEMENT LLC
$1.27MNew
RAYMOND JAMES FINANCIAL INC
$844.8K-4.7%
XTX Topco Ltd
$751.1K+277.1%
T3 Companies, LLC
$741.5K+13.7%
Qube Research & Technologies Ltd
$601.0KNew
Verde Servicos Internacionais S.A.
$562.0KNew
See all 62 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

IFRX key financials by period

Reported revenue, net income and operating margin by fiscal year, from InflaRx N.V.'s annual filings on SEC EDGAR.

InflaRx N.V. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$29.3K$-45.6M—
FY 2024$165.8K$-46.1M—
FY 2023$63.1K$-42.7M—
Source: IFRX filings on SEC EDGAR →

About InflaRx N.V. (IFRX): stock profile, AI score and financials

InflaRx N.V. (IFRX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IFRX at 25.4/100 on a composite quality score built from its SEC filings, placing it at rank #2,626 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), InflaRx N.V. reports quarterly revenue of $29.3K, net income of $-45.6M, free cash flow of $-35.4M. Top institutional holders of IFRX by reported 13-F value include SUVRETTA CAPITAL MANAGEMENT, TCG Crossover Management, FMR, based on the most recent SEC filings. IFRX trades on the Nasdaq exchange and files with the SEC under CIK 1708688. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IFRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InflaRx N.V. directly from SEC EDGAR.

SEC EDGAR: CIK 1708688 →